CSF2 and colitis: Our study therefore suggests a novel route of action for Bacillus-based probiotic, CP9, where we propose involvement of CP9 in activating GM-CSF and consequently moderating TLR signaling pathways, contributing to alleviating ETEC-induced colitis in IPEC-J2 cells.